September 18, 2014

Vanderbilt Heart and Vascular Institute is participating in a global clinical trial to test the safety and efficacy of the world's smallest pacemaker. Read more...

Initiative seeks to develop therapies to combat Ebola


Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses. Read more...

Peabody collaboration encourages teens to become "makers of content"


Teens huddled around a bank of computers at the Nashville Public Library on a recent afternoon might have appeared to be engaged in mindless video games. Instead, they were utilizing Minecraft as a tool to re-envision an East Nashville housing community. Read more...